UNSPSC 51342312: Entecavir hydrate

This classification denotes an antiviral agent with the molecular formula C12H15N5O3.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5968Y6H45M, chemically known as 6h-purin-6-one, 2-amino-1,9-dihydro-9-((1s,3r,4s)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)- monohydrate, but more generally known as entecavir hydrate, which bears US NIH Compound Identifier 170342. European Medicines Agency schedules entecavir hydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21468.

Most nations, for tariff purposes, schedule entecavir hydrate under HS 29335995. SMILES: C=C1[C@H](C[C@@H]([C@H]1CO)O)N2CNC3C2NC([NH]C3=O)N.O.

UNSPSC 51342312 Entecavir hydrate is a Commodity code for a specific antiviral pharmaceutical product, but the recent state and local opportunities tagged under it do not reflect procurement of entecavir itself. Instead, the code shows minimal recent relevant activity; the two posted opportunities involve naloxone (an opioid antagonist), doxycycline hyclate, ciprofloxacin hydrochloride, and drug deactivation systems—products outside the scope of the entecavir commodity. When state and local procurement offices do source antiviral pharmaceuticals under related codes, they typically work through piggyback contracts, cooperative purchasing consortia such as MMCAP, and competitive bidding processes (IFB or RFQ) to secure bulk quantities for public health stockpiles, emergency preparedness programs, or treatment protocols administered by state departments of health, county health departments, and public health clinics.

The geographic spread of pharmaceutical procurement at the state and local level spans Illinois and Florida in the recent record, with activity driven by state departments of public health and county health authorities. Illinois Department of Public Health awarded a pharmaceutical piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 for $2,999,999.11 over 12 months with renewal options, procuring multiple antibiotic and antiviral products through an Invitation for Bid process. Seminole County, Florida issued an IFB on June 30, 2026 (due July 26, 2026) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries. Neither opportunity directly solicits entecavir hydrate, indicating the code may be misaligned with current state and local pharmaceutical purchasing activity or that entecavir procurement occurs outside recently posted solicitations visible in public records.